The involvement of α-synuclein in neurodegeneration was originally identified in the attempt to characterize neurofibrillary lesions in Alzheimer’s disease (AD) by the use of anti-tau antibodies, which labelled cytosolic proteins of approximately 19 kDa [124]. This evidence concerns the gene MAPT and Alzheimer disease.